Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1VmdEeC
Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1NSObIo
1
Cost of #Pharma Business Set to Increase in #India - User Fees Rising Six-Fold | TwoFour Insight Group buff.ly/1TK8qan
Sanofi Obtains Indian Patent for Azabicycloalkane Derivatives - TwoFour Insight Group twofourinsight.com/sanofi-ob…
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/1TyVkQ7
Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/1RrmeC7
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1UdDi2M
Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/25mwAjG
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1RqLMiH
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/25lXKHB
Newron #Pharma of #Italy Withdraws Indian Patent Application for Antimigraine Drug - TwoFour Insight Group #India buff.ly/1TzWL0P
USFDA Approves Jubilant HollisterStier's First ANDA for an Injectable - #India #pharma TwoFour Insight Group buff.ly/1UdD7Vb
Indoco Receives USFDA Nod for Its Goa Plant II - TwoFour Insight Group #India #pharma buff.ly/1OWY201
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/1TvAxwM
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/1Ro0Qxz
Drugs Technical Advisory Board (DTAB) Recommends Against Generic Substitution in #India - #pharma buff.ly/25kgsPN
India’s new patent policy spurs debate over implications for pharma statnews.com/pharmalot/2016/… via @statnews
USFDA Puts Yunnan Hande Bio-Tech on Import Alert - TwoFour Insight Group #China #pharma buff.ly/20sFUvx
Generic Crestor Market to Become Crowded in Near Future - TwoFour Insight Group #India #pharma buff.ly/1YTjeEn
Accord Receives ANDA Approval for Generic Treanda - TwoFour Insight Group #India #pharma buff.ly/1s5JUHF
